Seroprevalence of hepatitis-C antibodies in blood donors

Pakistan Journal of Medical Sciences

Volumn 18, Issue 3, 2002, Pages 193-196

  Rahman, Mahfooz Ur ^a,b   Akhtar, Gul Naz ^a   Lodhi, Yasmin ^a  

^a Institute of Haematology and Blood Transfusion Service   (Pakistan)

^b Institute of Haematology and Blood Transfusion Service Punjab   (Pakistan)

Author keywords

Blood safety; Prevalence of HCV antibodies in blood donors

Indexed keywords

EID: 0013017031     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. McCaughan GW, McGuiness PH, Bishop GA, Painter DMF, Lien AS Tulloch R, Wylie BR, Archer GT. Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA positive volunteer blood donors. Med J Aust 1992; 157:231-33.
2. Lenette EH, Smith TF. Laboratory Diagnosis of viral infections. Third Edition, Marcel Decker, New York 1999: Chapter 22: 449-457.
3. National Institute of Health. Consensus development Conference Panel statement: management of Hepatitis C. Hepatology 1997;26(suppl 1) 2S-10S.
4. Farci P, Alter HJ, Shimoda A, Govindarajan S, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med 1996; 335:631-34.
5. Barrera JM, Bruguera M, Ercilla MG et al. Persistent hepatitis C viremia after acute self-limiting postransfusion hepatitis C. Hepatology 1995;21: 639-44.
6. Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-1340.
7. Bruix J, Barrera JM, Calvet X et al. Prevalence of antibodies to Hepatitis C in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2:1004-1006.
8. Zein NN, Rakela J, Krawitt EL et al. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125: 634-39.
9. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first and second generation assays. N Engl J Med 1991; 325:1325-1329.
10. Corona R, Prignano G, Mele A et al. Heterosexual and homosexual transmission of hepatitis C virus: relation with Hepatitis B and human immunodeficiency virus type 1. Epidemiol Infect 1991; 107:667-72.
11. Paccagnini S, Principi N, Massironi E et al. Perinatal transmission and manifestation of Hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995; 14: 195-199.
12. Al-Faleh FZ, Ayoola EA, Al-Jaffry M et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study. Hepatology 1991; 14: 215-18.
13. Kassler WJ, Haley C, Jones WK et al. Performance of a rapid, on site human immunodeficiency virus antibody assay in a public health setting. J Clin Microbiol 1995; 33: 2899-2902.
14. Carpenter AB. Enzyme-linked immunoassays. In Rose NR, Conway de Marcario E, Folds JD, Lane EC, Nakamura RM,eds Manual of Clinical Laboratory Immunology. 5th ed Washington DC: ASM Press, 1997: 39-48.
15. Safe blood and blood Products. Costing Blood Transfusion Services. Case Study Zimbabwe; 1998: WHO/BLS/98.8, 54-63.
16. Annual Report 1995. Blood Transfusion Services information System, Unit Sistem Maklumat Dan Dokumentasi, Kementerian Kesihatan Malaysia, Appendix 4, Mei 1996.
17. Schmunis A, Zicker F, Segura EL, Del Pozo AE. Transfusion transmitted infectious diseases in Argentina 1995 through 1997. Transfusion 2000;40:1048-1053.
18. Buffington J, Shapiro CN, Holman RC et al. Multiple unconfirmed-reactive screening tests for viral antibodies among blood donors. Transfusion 1994; 34: 5, 371-375.
19. Mackenzie WR, Davis JP, Peterson DE, Hibbard AJ et al. Multiple false positive serologic tests for HIV, HTLV-1 and hepatitis C following influenza vaccination. JAMA 1992; 268:1015-7.